EGM
JSPR icon

Engineers Gate Manager’s Jasper Therapeutics JSPR Stock Holding History

Engineers Gate Manager’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.9K Buy
26,131
+11,874
+83% +$16.5K ﹤0.01% 2117
2025
Q4 		$26.1K Buy
+14,257
New +$28.6K ﹤0.01% 2019
2025
Q3 		– Sell
-13,972
Closed -$77.5K – 2354
2025
Q2 		$77.5K Buy
+13,972
New +$68.8K ﹤0.01% 2026

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Engineers Gate Manager's JSPR Position: Q1 2026 in Review

Engineers Gate Manager increased its Jasper Therapeutics (JSPR) stake by 83% in Q1 2026, buying an estimated $16.5K and bringing the position to 26,131 shares worth $22.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2117.

Engineers Gate Manager first reported a position in JSPR in Q2 2025 and has held it in 3 quarters since. The position peaked at $77.5K in Q2 2025. 58 funds tracked by Wall St. Rank hold JSPR as of Q1 2026.

  • Engineers Gate Manager held 26,131 shares of Jasper Therapeutics worth $22.9K as of Q1 2026.
  • Engineers Gate Manager bought 11,874 Jasper Therapeutics shares in Q1 2026, an estimated $16.5K.
  • Jasper Therapeutics made up ﹤0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #2117 holding.
  • Engineers Gate Manager first reported a position in Jasper Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • Engineers Gate Manager's Jasper Therapeutics position peaked at $77.5K in Q2 2025.
  • 58 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.